Brief: Edwards Lifesciences Q4 Adjusted EPS USD 0.59 Vs. IBES Estimate USD 0.55
11/02/2025 21:15
Feb 11 (Reuters) - Edwards Lifesciences Q4 gross profit USD 1,093.6 million. * Q4 EPS USD 0.65 * Q4 sales USD 1,385.8 million vs. IBES estimate USD 1,358 million * outlook Q1 adjusted EPS USD 0.58-0.64 * outlook Q1 sales USD 1,350-1,430 million
Recent news on Edwards Lifesciences
See all newsFDA flags Edwards heart-valve delivery system issue after death, injury (updated)
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals